Injective Says SEC Weighs a US Stock Perpetuals Framework

High attention and emotional sentiment detected.

So far, there is no SEC order, no-action letter, or press release clearing firms to launch SEC stock perpetuals. Instead, regulators have opened a request for comment and a notice-registration path. A few firms have started filing into it.

What the SEC Actually Did on Stock Perpetuals

On June 18, 2026, the SEC and the CFTC jointly requested public comment on how to define novel products. According to law-firm analyses, the request asks a specific question. Should a cash-settled perpetual that tracks an equity count as a “security future”?

That filing carries the reference S7-2026-21, with release numbers 33-11424 and 34-105735. The comment window ran for about 60 days, and commenters widely cited August 24, 2026 as the deadline. Therefore the process is still at the consultation stage, not approval.

SEC Chair Paul S. Atkins called the clarification “long overdue.” CFTC Chair Michael Selig is the counterpart on the commodities side. In short, the agencies are asking questions, not issuing product approvals.

The groundwork goes back further. In a September 2025 joint statement, Atkins and then-Acting CFTC Chair Caroline D. Pham named perpetual contracts as an onshoring priority. Still, that language was policy signaling rather than a rule.

Coinbase Filings Lead the Real Pipeline

The most concrete move came from Coinbase, not Injective. On September 3, 2026, Coinbase announced notice-registration filings dated September 1 for its derivatives exchange and its broker.

Specifically, Coinbase Derivatives filed a Form 1-N, and Coinbase Financial Markets filed a Form BD-N. These filings use a path under Section 6(g) of the Exchange Act. Notably, they do not authorize trading, because CFTC product approval is still required.

“We’re working to bring single stock perps to the US,” Coinbase said in its official post on the filings. Coinbase product chief Faryar Shirzad added that equity perps have “proven demand internationally.”

Other names sit in the same queue. A secondary outlet reported on September 8 that the SEC acknowledged KalshiEX and Bitnomial 6(g) registrations. However, that report is not yet confirmed on sec.gov. Meanwhile CME cleared a separate path earlier in 2026 for cash-settled single-stock futures. Those are dated contracts, not perpetuals.

Why Equity Perpetuals Sit in a Gray Zone

A perpetual future is a cash-settled contract that tracks an asset with no expiry date. Instead of a delivery date, a funding rate between longs and shorts keeps the price tethered to the underlying.

When that structure is applied to a single stock, holders get price exposure only. As a result, they receive no voting rights, no dividends, and no share delivery. Offshore venues already run these markets around the clock.

U.S. access stalled for a specific reason. Single-name equity derivatives generally fall under the joint SEC-CFTC “security futures” regime, or possibly under security-based swaps. Consequently, listing one requires a registered exchange, a clearinghouse, brokers, margin rules, and sign-off from both agencies.

The classification question is genuinely open. Equity perps could end up treated as futures, as security futures, or as security-based swaps. Former SEC counsel Ashley Ebersole estimated that a full rulemaking path could take 10 to 12 months.

Where Injective Fits Into SEC Stock Perpetuals

Injective’s own regulatory milestones are real, but they are separate boxes. For example, Injective Institutional Services became an SEC-registered transfer agent effective August 19, 2026, which covers recordkeeping, not stock-perp listings.

In addition, CFTC-regulated INJ futures went live on Bitnomial on April 15, 2026. Injective and its Helix exchange also run on-chain stock and pre-IPO perpetuals. Still, those are offshore, synthetic markets, not SEC-cleared U.S. security futures.

Injective’s tweet also claims $81 billion in cumulative volume. However, that figure is the project’s own number, and it was not independently verified against on-chain explorers. By comparison, a November 2025 Messari report pegged cumulative RWA perp volume near $6 billion.

What the Market and Analysts Are Saying

The price reaction stayed muted. Around the post on September 11, INJ traded near $5.85 to $5.96. That marked a drop of roughly 2.7% on the day, with a market cap close to $590 million. Earlier in the week, INJ had already rallied from about $4.80 on a Robinhood listing. As a result, the move did not line up cleanly with the tweet.

Coinbase stock told a similar story. COIN reportedly rose about 10% on its own September 3 filing news, not on Injective’s later post. In other words, the market rewarded the concrete filing, not the marketing framing.

Analysts are also cautious. Traders on X flagged Coinbase’s filing as paperwork rather than a launch. Meanwhile Citadel Securities reportedly urged regulators to keep the SEC primary on equity-linked products. That push points to a turf fight rather than consensus.

This article is informational and not financial advice. Crypto assets are volatile, and readers should do their own research before making any decision.

What Comes Next for SEC Stock Perpetuals

The next signals are specific and trackable. First, watch for the SEC and CFTC to publish responses to the S7-2026-21 comments. Commenters include Ondo, dYdX Labs, and the Hyperliquid Policy Center.

Second, watch whether regulators formally classify cash-settled equity perps, since that decision unlocks or blocks the product. For now, SEC stock perpetuals remain a real but incomplete process. No firm can trade them onshore yet.